Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04463693 · ClinicalTrials.gov registry record · Phase 4
Shoulder Contraceptive Implant Study
A Phase 4 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT04463693 is a Phase 4 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 5 participants.
The verdict
NCT04463693, a Phase 4 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study will be the first to establish pharmacokinetic curves for the etonogestrel contraceptive implant with scapular subdermal insertion. By obtaining this pharmacokinetic data, the investigators can compare this data to already published pharmacokinetic data with conventional implant insertion. This comparison can provide some reassurance that the absorption and distribution of etonogestrel from the contraceptive implant with scapular insertion is similar to that found with conventional insertion. With similar pharmacokinetic properties, the investigators would expect scapular insertion of the implant to maintain similar contraceptive efficacy for the populations of women that may benefit from this alternative insertion site. Preliminary safety data will also enrich the understanding of any potential insertion site side effects with subdermal scapular implant insertion, as the investigators currently only have a single case report with side effect outcomes. The investigators can then use this pilot data to support future larger investigations on subdermal scapular implant insertion given its complete avoidance of the neurovascular complications associated with arm insertion.
Interventions
- DRUG Etonogestrel implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2020-10-14 |
| Est. Completion | 2022-02-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04463693
The ClinicalTrials.gov registry entry for NCT04463693 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Etonogestrel implant is the first listed.
NCT04463693 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04463693 about?
NCT04463693 is a clinical study titled "Shoulder Contraceptive Implant Study". This study will be the first to establish pharmacokinetic curves for the etonogestrel contraceptive implant with scapular subdermal insertion. By obtaining this pharmacokinetic data, the investigators can compare this data to already published pharmacokinetic data with conventional implant insertion...
What is the current status of trial NCT04463693?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2020-10-14. Estimated completion is 2022-02-15.
What interventions are being tested in trial NCT04463693?
The interventions under investigation include: Etonogestrel implant (DRUG).
Who is sponsoring clinical trial NCT04463693?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.